Evidence map›Paper›PMID 33879984›Full record

ArticleDigital signal processing2021

Unknown uncertainties in the COVID-19 pandemic: Multi-dimensional identification and mathematical modelling for the analysis and estimation of the casualties.

Onder Tutsoy, Kemal Balikci, Naime Filiz Ozdil

Abstract read
In one paragraph

Article in Digital signal processing, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Onder TutsoyAdana Alparslan Turkes Science and Technology University, Adana, Turkey.
Kemal BalikciOsmaniye Korkut Ata University, Osmaniye, Turkey.
Naime Filiz OzdilAdana Alparslan Turkes Science and Technology University, Adana, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insights about the dominant dynamics, coupled structures and the unknown uncertainties of the pandemic diseases play an important role in determining the future characteristics of the pandemic diseases. To enhance the prediction capabilities of the models, properties of the unknown uncertainties in the pandemic disease, which can be utterly random, or function of the system dynamics, or it can be correlated with an unknown function, should be determined. The known structures and amount of the uncertainties can also help the state authorities to improve the policies based on the recognized source of the uncertainties. For instance, the uncertainties correlated with an unknown function imply existence of an undetected factor in the casualties. In this paper, we extend the SpID-N (Suspicious-Infected-Death with non-pharmacological policies) model as in the form of MIMO (Multi-Input-Multi-Output) structure by adding the multi-dimensional unknown uncertainties. The results confirm that the infected and death sub-models mostly have random uncertainties (due undetected casualties) whereas the suspicious sub-model has uncertainties correlated with the internal dynamics (governmental policy of increasing the number of the daily tests) for Turkey. However, since the developed MIMO model parameters are learned from the data (daily reported casualties), it can be easily adapted for other countries. Obtained model with the corresponding uncertainties predicts a distinctive second peak where the number of deaths, infected and suspicious casualties disappear in 240, 290, and more than 300 days, respectively, for Turkey.

Indexed as

COVID-19 casualtiesExtended SpID-N modelNon-pharmacological approachesParametric modelSystem identificationUncertainties

Identifiers

PMID33879984
PMCPMC8048408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.